ASTRAZENECA BOSS SUGGESTS UK'S RELIANCE ON OXFORD JAB HAS HELPED CONTROL COVID ADMISSIONS

The chief executive of AstraZeneca (AZ) has told Sky News that the company's decision to begin seeking a modest profit from its COVID vaccine is unlikely to kick in until next year. © Associated Press The Oxford-AstraZeneca vaccine has been sold at cost since it first became available Pic: AP Pascal Soriot said this was because it still had many doses of the jab to supply that it had pr...

Source: